Oxford-AstraZeneca Vaccine Rolled Out In U.K.

The video discusses the rollout of the Oxford AstraZeneca vaccine in the UK, highlighting the first recipients and their reactions. It compares the Oxford vaccine with the Pfizer BIONTECH vaccine, noting the former's cost-effectiveness and easier storage requirements. The UK's strategy to delay the second dose to 12 weeks is also covered, with mention of other countries following suit.

Who was the first person to receive the Oxford AstraZeneca vaccine?

• A university student

• An 82-year-old man

• A 65-year-old woman

• A healthcare worker

What is one of the main advantages of the Oxford vaccine compared to the Pfizer BIONTECH vaccine?

• It requires fewer doses

• It is available in more countries

• It is more effective

• It is cheaper and easier to store

Why is the Oxford vaccine considered easier to use?

• It can be administered orally

• It does not require super cold storage

• It is a single-dose vaccine

• It has fewer side effects

What is the UK's strategy for administering the second dose of the vaccine?

• Administering it after 3 weeks

• Administering it after 15 weeks

• Administering it after 12 weeks

• Administering it after 6 weeks

Which countries are following the UK's approach to vaccine dosing?

• Only the US

• The US and other countries

• Only European countries

• No other countries